Selected article for: "simplex virus and virus replication"

Author: Song, Jae-Hyoung; Shim, Aeri; Kim, Yeon-Jeong; Ahn, Jae-Hee; Kwon, Bo-Eun; Pham, Thuy Trang; Lee, Jongkook; Chang, Sun-Young; Ko, Hyun-Jeong
Title: Antiviral and Anti-Inflammatory Activities of Pochonin D, a Heat Shock Protein 90 Inhibitor, against Rhinovirus Infection
  • Document date: 2018_5_2
  • ID: 0bwf8f1i_5
    Snippet: Several inhibitors of Hsp90 are known and their potential as therapeutic drugs have been tested at both preclinical and clinical stages (Neckers and Workman, 2012) . Radicicol is a natural product and is reported as one of the most potent Hsp90 inhibitors (Moulin et al., 2005) . It can selectively block the function of ATPase and the chaperone function of Hsp90 (Roe et al., 1999; Zhou et al., 2010) . Despite its potent activity, radicicol has lab.....
    Document: Several inhibitors of Hsp90 are known and their potential as therapeutic drugs have been tested at both preclinical and clinical stages (Neckers and Workman, 2012) . Radicicol is a natural product and is reported as one of the most potent Hsp90 inhibitors (Moulin et al., 2005) . It can selectively block the function of ATPase and the chaperone function of Hsp90 (Roe et al., 1999; Zhou et al., 2010) . Despite its potent activity, radicicol has labile moieties that are rapidly inactivated in vivo, leading to poor efficacy in practice (Zhou et al., 2010) . Pochonin D was originally isolated from Pochonia chlamydosporia and is a radicicol analog with potential Hsp90 inhibitory ability (Moulin et al., 2005; Wang et al., 2016; Choe et al., 2017) . It has been shown to inhibit the replication of Herpes Simplex Virus 1 (HSV1) and the parasitic protozoan Eimeria tenella (Hellwig et al., 2003) .

    Search related documents:
    Co phrase search for related documents
    • inhibitory ability and natural product: 1
    • inhibitory ability and potent activity: 1
    • natural product and potent activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • natural product and therapeutic drug: 1, 2, 3, 4
    • poor efficacy and potent activity: 1
    • poor efficacy and therapeutic drug: 1, 2
    • potent activity and therapeutic drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10